LNTH Q1 2019 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$5B

Q1 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$87M+4.7% YoY

Gross Profit

$44M51.0% margin

Operating Income

$16M18.7% margin

Net Income

$10M11.5% margin

EPS (Diluted)

$0.25

QoQ Revenue Growth

+0.3%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

-$82,000

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$444M

Total Liabilities

$361M

Stockholders' Equity

$83M

Cash & Equivalents

$112M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$87M	$83M	+4.7%
Gross Profit	$44M	$42M	+4.2%
Operating Income	$16M	$15M	+6.8%
Net Income	$10M	$8M	+21.2%

Revenue Segments

Product Revenue, Net

$86M99%

License and Royalty Revenues

$527,0001%